CryoCell International Inc (CCEL)vsThe Ensign Group Inc (ENSG)
CCEL
CryoCell International Inc
$3.42
-3.36%
HEALTHCARE · Cap: $27.55M
ENSG
The Ensign Group Inc
$168.59
-0.20%
HEALTHCARE · Cap: $9.75B
Smart Verdict
WallStSmart Research — data-driven comparison
The Ensign Group Inc generates 16760% more annual revenue ($5.27B vs $31.28M). ENSG leads profitability with a 6.9% profit margin vs -8.5%. CCEL appears more attractively valued with a PEG of 1.34. ENSG earns a higher WallStSmart Score of 63/100 (C+).
CCEL
Hold39
out of 100
Grade: F
ENSG
Buy63
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+34.8%
Fair Value
$5.12
Current Price
$3.42
$1.70 discount
Margin of Safety
-45.8%
Fair Value
$145.32
Current Price
$168.59
$23.27 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 129 in profit
Conservative balance sheet, low leverage
18.4% revenue growth
Earnings expanding 21.9% YoY
Areas to Watch
Smaller company, higher risk/reward
Revenue declined 3.6%
Earnings declined 80.5%
Distress zone — elevated risk
Moderate valuation
6.9% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : CCEL
The strongest argument for CCEL centers on Return on Equity, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bull Case : ENSG
The strongest argument for ENSG centers on Revenue Growth, EPS Growth. Revenue growth of 18.4% demonstrates continued momentum. PEG of 1.48 suggests the stock is reasonably priced for its growth.
Bear Case : CCEL
The primary concerns for CCEL are Market Cap, Revenue Growth, EPS Growth.
Bear Case : ENSG
The primary concerns for ENSG are P/E Ratio, Profit Margin.
Key Dynamics to Monitor
CCEL profiles as a turnaround stock while ENSG is a growth play — different risk/reward profiles.
ENSG carries more volatility with a beta of 0.69 — expect wider price swings.
ENSG is growing revenue faster at 18.4% — sustainability is the question.
ENSG generates stronger free cash flow (65M), providing more financial flexibility.
Bottom Line
ENSG scores higher overall (63/100 vs 39/100) and 18.4% revenue growth. CCEL offers better value entry with a 34.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CryoCell International Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.
The Ensign Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?